OncoMed Pharmaceuticals Garners $999,000 New Financing

  • Feed Type
  • Date
    12/31/2009
  • Company Name
    OncoMed Pharmaceuticals
  • Mailing Address
    800 Chesapeake Drive Redwood City, CA 94063
  • Company Description
    OncoMed Pharmaceuticals is discovering and developing monoclonal antibodies and small molecules capable of destroying “cancer stem cells”, a recently discovered type of cell believed to seed the growth of cancers and underlie cancer’s ability to spread and take root in tissues.
  • Website
    http://www.oncomed.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $999,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    De Novo Ventures

Trending on Xconomy